Thrombophilia work-up and clinical outcomes in Indian patients with unprovoked venous and arterial thrombosis aged 18-50 years | BTVB Bioequivalence of von Willebrand factor-containing concentrates: implications for von Willebrand disease | BTVB Cardiovascular risk in hormone replacement therapy | BTVB Direct oral anticoagulants: does one dose fit all? Why, when and how testing | BTVB Cardiovascular risk profile evolution over 15 years: CV-PREVITAL vs Moli-sani Study | BTVB Launch of National Registry for Congenital Hematological Disorders in Palestine: Haemo-PAL | BTVB
Skip to main content Skip to main navigation menu Skip to site footer
Bleeding, Thrombosis and Vascular Biology

Editor-in-Chief: Giovanni de Gaetano, Italy | eISSN: 2785-5309

  • About the Journal
  • Copyright
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Supplements
    • ICTHIC 2026
    • SISET 2025
    • ICTHIC 2024
  • Register
  • Login
  • Search
  • Contacts
0.5
Impact Factor 2025
0.6
CiteScore 2025
This journal has not published any issues.
0.5
Impact Factor 2025
0.6
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis

    Robert Parambi, Nicole Ziliotto, Francesco Bernardi , Marcello Baroni , Richard W Browne , Dejan Jakimovski, Bianca Weinstock-Guttman, Robert Zivadinov, Murali Ramanathan
    17-10-2022
    https://doi.org/10.4081/btvb.2022.41
    2760
    PDF: 430
    Supplementary Files: 123
  • Beyond the usual workup: severe hypertriglyceridemia as a potential cause of cerebral venous thrombosis

    Arnaud Lapostolle, Randa Khani-Bittar, Julie Mazoyer, Astrid De Liege, Bertrand Degos
    15-07-2026
    https://doi.org/10.4081/btvb.2026.477
    0
    PDF: 0
  • Tumor necrosis factor superfamily in multiple sclerosis: from pathology to therapeutic implications

    Federica Azzolini, Antonio Bruno, Ettore Dolcetti, Diego Centonze, Fabio Buttari
    03-05-2023
    https://doi.org/10.4081/btvb.2023.66
    1415
    PDF: 495
  • Is transient ischemic attack a minor stroke?

    Ettore Dolcetti, Antonio Bruno, Diego Centonze
    12-05-2022
    https://doi.org/10.4081/btvb.2022.31
    900
    PDF: 0
  • Persistence of functional anti-PF4 antibodies and neutrophil activation in vaccine-induced immune thrombotic thrombocytopenia

    Eleonora Petito, Anna Maria Mezzasoma, Emanuela Falcinelli, Chiara Conti, Erica De Candia, Raimondo De Cristofaro, Silvia Sorrentino, Gian Marco Podda, Mariangela Scavone, Anna Falanga, Marina Marchetti, Luca Barcella, Stefania Basili, Lucia Stefanini, Andrea Boccatonda, Laura Contino, Patrizia Sciancalepore, Igor Florio, Egidio Imbalzano, Rossella Marcucci, Angela Rogolino, Patrizia Noris, Marta Panella, Rita Santoro, Maria Costanza Turi, Gaetano Vaudo, Rosa Curcio, Paolo Gresele
    18-11-2025
    https://doi.org/10.4081/btvb.2025.400
    782
    PDF: 129
    HTML: 167
  • CO12 | Left internal carotid artery thrombosis in a patient with antiphospholipid antibody syndrome successfully treated with eculizumab A. Hoxha1, L. Nico2, F. Viaro3, L. Fabris1, Y.F. Herrera1, M. Munari4, C. Baracchini3, F. Causin2, P. Simioni1 | 1Internal Medicine Unit, Thrombotic and Haemorrhagic Centre, Department of Medicine - DIMED, University of Padua; 2Neuradiology Unit, University Hospital of Padua; 3Stroke Unit, Neurology Department, University of Padua; 4Intensive Care Unit, University Hospital of Padua, Italy

    22-10-2025
    https://doi.org/10.4081/btvb.2025.216
    608
    PDF: 0
  • Cancer-associated ischemic stroke: current knowledge and future directions

    Ronda Lun, Deborah M. Siegal
    16-05-2024
    https://doi.org/10.4081/btvb.2024.117
    2891
    PDF: 834
  • CO51 | Novel biomarkers of neurological damage in acute immune-mediated thrombotic thrombocytopenic purpura A. Truma1,2, I. Mancini1, F. Verde2,3, J. A. Giannotta1, A. Artoni1, B. Ferrari1, P. Agosti1,2, M. Gagliardi1, A. Ratti3,4, N. Ticozzi2,3, F. Peyvandi1,2 | 1Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan; 2Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan; 3Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan; 4Università degli Studi di Milano, Department of Medical Biotechnology and Translational Medicine, Milan, Italy

    22-10-2025
    https://doi.org/10.4081/btvb.2025.261
    505
    PDF: 0
  • Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled trial"

    Vittorio Pengo
    01-07-2025
    https://doi.org/10.4081/btvb.2025.179
    977
    PDF: 300
  • Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review

    Sarah Gallitto, Thomas C. Varkey, Jacob Lahti
    13-12-2024
    https://doi.org/10.4081/btvb.2024.131
    3222
    PDF: 426
  • PO68 | RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH CANCER AND MIGRAINE: A COHORT ANALYSIS AMONG DANISH NATIONAL HEALTH SURVEY PARTICIPANTS O. Rosenkrantz1, P. Szentkúti1, L. Amdisen1, E. Horváth-Puhó1, A.L. Pedersen1, H.E. Bøtker2, H. Elser1|3, J.P. Vandenbroucke1|4|5, H.T. Sørensen1 | 1Department of Clinical Epidemiology and Center for Population Medicine, Aarhus University Hospital and Aarhus University, Denmark; 2Department of Cardiology, Aarhus University Hospital, Department of Clinical Medicine, University of Aarhus, Denmark; 3Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA; 4Department of Clinical Epidemiology, Leiden University Medical School Leiden, The Netherlands; 5School of Hygiene and Tropical Medicine, London, UK

    Società Italiana di Emostasi e Trombosi
    16-04-2026
    https://doi.org/10.4081/btvb.2026.557
    278
    PDF: 86
  • PO29 | CANADIAN INSIGHTS INTO THE MANAGEMENT OF BREAKTHROUGH THROMBOSIS S. Ramdani1, C. Séguin2 | 1Division of Hematology, Post-Graduate Medical Education Program, McGill University, Montreal; 2Division of Hematology, Department of Medicine, McGill University Health Center, Montreal, Canada

    Società Italiana di Emostasi e Trombosi
    16-04-2026
    https://doi.org/10.4081/btvb.2026.524
    249
    PDF: 68
1 - 12 of 12 items

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article
  • Index of Authors

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review
Vol. 5 No. 2 (2026)
To P or not to P. That is the wrong question.
Augusto Di Castelnuovo et al.
10 June 2026
Vol. 5 No. 2 (2026)
Why medical fiction privileges certain disease manifestations
Raffaele Landolfi
15 May 2026
Vol. 5 No. 2 (2026)
ERRATUM - Neurovascular protective effects of nutritional interventions in ischemic brain injury
Pooja Mishra et al.
15 May 2026

indexing

INDEXING
  • Scopus
  • Web of Science
  • DOAJ
  • Google Scholar
  • OpenAlex
  • Analytics

Keywords

Bleeding, Thrombosis and Vascular Biology

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

eISSN: 2785-5309

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors
Themes by Openjournaltheme.com

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy